Literature Monitoring for Biotechs
Unexpected Safety Findings are Costly
Adverse events hidden in the literature can derail the approval of promising compounds, cause inspection findings, re-work and submission failures. Protect your investment with compliant and efficient literature processes powered by biologit MLM-AI. Get in touch for a demo and free trial.
Find every adverse event from the literature
Get to inspection-ready literature process
Eliminate risks from regulatory submissions
Liberate specialists for high value work
ʽʽ We are glad to use the biologit MLM-AI platform in our routine pharmacovigilance activities. Thank you for your product that makes our job easier. ʼʼ
Complete Solution for Compliant Regulatory Searches
biologit MLM-AI is a complete pharmacovigilance literature monitoring platform built for biotechs. Meet all FDA and EMA regulatory literature requirements faster, with high quality and from a modern interface the entire team can collaborate. Leverage our unique AI technology fine tuned for pharmacovigilance that delivers up to 70% workflow savings.
Global and Local Literature Out of the Box
Break free from expensive licenses for literature databases. The global and regional coverage of the biologit Database is available out of the box for all your
regulatory search requirements.
Over 55 million citations, 110,000 journals and 130+ countries, updated daily, including PubMed, Crossref, DOAJ, and a growing list of regional databases.
📖Learn more in Our guide to Literature Databases for Regulatory Searches
Compliant, Validated and Audit-Ready
biologit MLM-AI is a fully validated platform hosted on secure EU data centers, built following best industry practices and ready for your regulatory needs: compliant with GVP-VI guidelines for medical literature monitoring, and role-based user management and audit trail features to ensure FDA CFR-11 compliance.